期刊文献+

经颈静脉直接肝内门体分流术治疗肝硬化顽固性腹腔积液效果及其影响因素

Effect of transjugular direct intrahepatic portosystemic shunt for treating refractory ascites in liver cirrhosis patients and impact factors
下载PDF
导出
摘要 目的观察经颈静脉直接肝内门体分流术(DIPS)治疗肝硬化顽固性腹腔积液(RA)的效果及其影响因素。方法回顾性分析45例接受经颈静脉DIPS治疗的肝硬化RA患者,观察手术成功率及手术相关并发症。于DIPS次日开始随访12个月,比较术前与术后3、6、12个月实验室检查(白蛋白、总胆红素、凝血酶原时间、血氨)、门体静脉压力梯度(PSG)、Child-Pugh评分及分级、RA缓解率、肝性脑病(HE)发生率、分流道通畅率和生存率等指标;以单因素及多因素logistic回归分析观察术后3个月RA未缓解的影响因素。结果DIPS成功率100%。随访期间患者生存率100%。术前与术后3、6、12个月之间,除凝血酶原时间外,其余指标差异均有统计学意义(P均<0.05)。术后6、12个月RA缓解率及分流道通畅率均高于术后3个月(P均<0.05),术后3、6与12个月间HE发生率差异无统计学意义(P=0.607)。Child-Pugh评分、总胆红素、血氨为DIPS术后3个月RA未缓解的影响因素(P均<0.05),其中Child-Pugh评分为独立影响因素(P<0.05)。结论经颈静脉DIPS治疗肝硬化RA安全、有效;Child-Pugh评分是DIPS术后3个月RA未缓解的独立影响因素。 Objective To observe the effect of transjugular direct intrahepatic portosystemic shunt(DIPS)for treating refractory ascites(RA)in patients with liver cirrhosis and impact factors.Methods Data of 45 liver cirrhosis RA patients who underwent DIPS were retrospectively analyzed.The success rate of DIPS and relative complications were observed.The patients were followed up from the next day of DIPS for 12 months.Laboratory indexes,including albumin,total bilirubin,prothrombin time and serum ammonia,as well as portal pressure gradient(PSG),Child-Pugh scoring and grading,RA remission rate,incidence of hepatic encephalopathy(HE),shunt patency rate and survival rate were compared before and 3,6,12 months after DIPS.Then univariate and multivariate logistic regression analysis were used to explore the impact factors of non-remission of RA 3 months after DIPS.Results The success rate of DIPS was 100%.All patients were followed up,and the 12-month survival rate was 100%.Except for prothrombin time,significant differences of the other indicators were found between before and 3,6,12 months after DIPS(all P<0.05).The RA remission rate and shunt patency rate 6 and 12 months after DIPS were both higher than that 3 months after DIPS(all P<0.05),while the incidence of HE were not significant different among 3,6,and 12 months after DIPS(P=0.607).Child-Pugh score,total bilirubin and serum ammonia were all impact factors of non-remission of RA 3 months after DIPS(all P<0.05),and Child-Pugh score was the independent impact factor of non-remission of RA 3 months after DIPS(P<0.05).Conclusion Transjugular DIPS was safe and effective for treatment of cirrhotic RA.Child-Pugh score was the impact factor of non-remission of RA 3 months after DIPS.
作者 崔奇 翟少博 董方 程晴灏 石朝海 郝建枢 陈泉 CUI Qi;ZHAI Shaobo;DONG Fang;CHENG Qinghao;SHI Chaohai;HAO Jianshu;CHEN Quan(Clinical School of Medicine, Ningxia Medical University, Yinchuan 750000, China;Department of Vascular Surgery, Gansu Provincial People's Hospital, Lanzhou 730000, China;Clinical School of Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China)
出处 《中国介入影像与治疗学》 北大核心 2022年第5期268-272,共5页 Chinese Journal of Interventional Imaging and Therapy
基金 甘肃省重点实验室立项建设项目(18GR2RA033)。
关键词 肝硬化 高血压 门静脉 顽固性腹腔积液 经颈静脉直接肝内门体分流术 liver cirrhosis hypertension,portal refractory ascites direct intrahepatic portosystemic shunt
  • 相关文献

参考文献8

二级参考文献57

  • 1Landa-Galvdn HV, Milke-Garcia MP, Le6n-Oviedo C, et al. Nutritional assessment of alcoholic liver cirrhotic patients treated in the liver Clin- ic of the Mexico' s General Hospital [ J ]. Nutr Hosp, 2012,27 ( 6 ) : 2006-2014.
  • 2RomOn E, Garca-Galcerrn C, Torrades T, et al. Effects of an Exercise Programme on Functional Capacity, Body Composition and Risk of Falls in Patients with Cirrhosis :A Randomized Clinical Trial[ J ]. PLoS One,2016,11 (3) :e0151652.
  • 3Saad WE, Wagner CC, Lippert A, et al. Protective value of TIPS a- gainst the development of hydrothorax/ascites and upper gastrointesti- nal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO) [J]. Am J Gastroenterol,2013,108(10) :1612-1619.
  • 4Berry K, Lerrigo R, Liou IW, et al. Association Between Transjugular Intrahepatic Portosystemic Shunt and Survival in Patients WithCirrho- sis[ J]. Clin Gastroenterol Hepato1,2016,14 ( 1 ) : 118-123.
  • 5Patel S, Jinjuvadia R, Patel R, et al. Insulin Resistance is Associated With Significant Liver Fibrosis in Chronic Hepatitis C Patients:A Sys- temic Review and Meta-Analysis [ J ]. J Clin Gastroenterol, 2016,50 ( 1 ) : 80-84.
  • 6Graneini V, Trombetta M, Lunati ME, et al. Contribution of 13-cell dys- function and insulin resistance to diabetes : Role of severity of liver disease[J]. J Hepatol,2015,63(6) :1484-1490.
  • 7Krishnamurthy V, Zhang P, Ethiraj S, et al. Use of analytic morphomics of liver, spleen, and body composition to identify patients at risk foreir- rhosis [ J ]. Clin Gastroenterol Hepato1,2015,13 ( 2 ) :360-368. e5.
  • 8Nielsen MJ, Lehmann J, Leeming DJ, et al. Circulating Elastin Frag- ments Are Not Affected by Hepatic, Renal and Hemodynamic Chan- ges,But Reflect Survival in Cirrhosis with TIPS [ J ]. Dig Dis Sci, 2015,60( 11 ) :3456-3464.
  • 9Shounak M,Vimal R,Colin S,et al. A retrospective analysis of the im- pact of diastolic dysfunction on one-year mortality after transjugular in- trabepatic porto-systemic shunt, liver transplantation and non-trans- plant abdominal surgery in patients with cirrhosis [ J ]. Ann Gastroen- terol,2015,28 (3) :385-390.
  • 10Vulcano DS, Carvalhaes MA, Bakonyi Neto A. Evaluation of nutrition- al indicators and body composition in patients with advanced liver disease enrolled for liver transplantation [ J ]. Acta C ir Bras, 2013,28 (10) :733-739.

共引文献300

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部